Real-world effectiveness of dimethyl fumarate versus fingolimod in a cohort of patients with multiple sclerosis using standardized, quantitative outcome metrics

BACKGROUND: Prior studies suggest comparable effectiveness of dimethyl fumarate (DMF) and fingolimod (FTY) in multiple sclerosis (MS) using relapse, Expanded Disability Status Score (EDSS), and magnetic resonance imaging (MRI) lesion metrics. OBJECTIVE: Compare the real-world effectiveness of DMF ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hersh, Carrie M, Altincatal, Arman, Belviso, Nicholas, Kapadia, Shivani, de Moor, Carl, Rudick, Richard, Williams, James Rhys, Miller, Catherine, Koulinska, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744178/
https://www.ncbi.nlm.nih.gov/pubmed/35024161
http://dx.doi.org/10.1177/20552173211069852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744178/
https://www.ncbi.nlm.nih.gov/pubmed/35024161
http://dx.doi.org/10.1177/20552173211069852

Ejemplares similares